BARDA Innovation Initiatives in Medical Countermeasure Manufacturing

Article

Keynote SeriesPharmaceutical Technology and BioPharm International are sponsoring a Keynote Series session on strategies and innovations to reduce drug shortages and improve availability of medicines on the INTERPHEX 2016 Exhibit Hall Innovation Stage. Admission is free to any attendee with an exhibit hall pass.

Wednesday, April 27
1:30–3:15 pm
Strategies and Innovations to Reduce Drug Shortages and Improve Availability of Medicines
Aging facilities and equipment, inadequate operator training, a lack of quality control, tighter regulatory enforcement, and business decisions to eliminate unprofitable product lines contribute to ongoing shortages vital drug products. In this session, industry thought leaders will identify triggers for drug shortages, methods to avoid production line shutdowns and update facilities, and innovative industry efforts to fulfill demand for needed therapies. A Q&A session will follow the presentations.

2-2:30 pm
BARDA Innovation Initiatives in Medical Countermeasure Manufacturing
This presentation will describe the Biomedical Advanced Research and Development Authority’s (BARDA) program initiatives in manufacturing technologies for medical countermeasure advanced development.  Opportunities with the Centers for Innovation in Advanced Development & Manufacturing (CIADMs) and in Continuous Manufacturing will be discussed.

Speakers:
Michael Angelastro, Deputy Director for Manufacturing, Facilities and Engineering, Biomedical Advanced Research and Development Authority (BARDA)
Kimberly Sciarretta, PhD, Anti-Infectives (AI) Program, Division of CBRN Countermeasures, Biomedical Advanced Research and Development Authority (BARDA) 

To register: http://www.interphex.com/pharmtech

Other presentations in this session:

1:30–2 pm
An Interdisciplinary Approach to Address Drug Shortages

2:30-3 pm
Continuous Manufacturing for Rapid Process Development

View the complete Keynote Series Program

Recent Videos
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Drug Digest: Focusing on Solid Dosage Trends and Demand
Behind the Headlines, episode 7
Related Content